ClinicalTrials.gg
Sign In
CompletedNCT04051749Updated May 14, 2020

Incidence, Predictors and Validation of Risk Scores to Predict Myocardial Infarction After Noncardiac Vascular Surgery

An observational study in Complication of Surgical or Medical Care, sponsored by Centro Hospitalar De São João, E.P.E.. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-14.

Sponsored by Centro Hospitalar De São João, E.P.E. · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
306
Ages
18 Years and older
Sex
All
01

Study summary

Evaluate the incidence and predictors of post-operative mortality after noncardiac Vascular Surgery and compare the performance of existing risk scores.

02

Conditions studied

  • Complication of Surgical or Medical Care
03

In context

Lead sponsor

Centro Hospitalar De São João, E.P.E. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Consecutive patients submitted to elective arterial VS

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elective arterial Vascular Surgery
  • Patients > 18 years

Exclusion criteria

Exclusion Criteria:

  • Urgent/Emergent Surgery
  • Patients \< 18 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
306 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients submitted to VS

    Procedure: Noncardiac Vascular Surgery

Interventions

  • ProcedureNoncardiac Vascular Surgery

    Noncardiac Vascular Surgery

06

What researchers measure

Primary outcomes

  1. Major Cardiac Events

    Time frame: 30-day

Secondary outcomes

  1. Mortality

    Time frame: 30-day

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Reis P, Mourao J, Abelha F. Reply to the commentary on "Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study" [Int. J. Surg. 77 (2020) 181-2]. Int J Surg. 2020 Jul;79:47-49. doi: 10.1016/j.ijsu.2020.04.072. Epub 2020 May 11. No abstract available. PubMed 32438070 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2015 to primary completion in Apr 2015, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 8, 2019
First posted
Aug 9, 2019
StartActual
Jan 1, 2015
Primary completionActual
Apr 30, 2015
CompletionActual
Jul 31, 2015
Last update
May 14, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04051749
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Responsible party
Pedro Reis (Principal Investigator, Centro Hospitalar De São João, E.P.E.) — Principal investigator
First posted
Aug 9, 2019
Start date
Jan 1, 2015
Primary completion
Apr 30, 2015
Completion
Jul 31, 2015
Last update
May 14, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centro Hospitalar De São João, E.P.E.

Start the discussion